Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

654 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer.
Yee D, Rosen N, Favoni RE, Cullen KJ. Yee D, et al. Cancer Treat Res. 1991;53:93-106. doi: 10.1007/978-1-4615-3940-7_5. Cancer Treat Res. 1991. PMID: 1672092 Review.
Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-induced cell death--proliferative and anti-apoptotic effects.
Gooch JL, Van Den Berg CL, Yee D. Gooch JL, et al. Among authors: yee d. Breast Cancer Res Treat. 1999 Jul;56(1):1-10. doi: 10.1023/a:1006208721167. Breast Cancer Res Treat. 1999. PMID: 10517338
Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status.
Figueroa JA, Jackson JG, McGuire WL, Krywicki RF, Yee D. Figueroa JA, et al. Among authors: yee d. J Cell Biochem. 1993 Jun;52(2):196-205. doi: 10.1002/jcb.240520211. J Cell Biochem. 1993. PMID: 7690042
Inducible expression of herpes simplex virus thymidine kinase increases sensitivity to ganciclovir but does not enhance bystander effect in breast cancer cells.
Patil R, Chavez JB, Yee D. Patil R, et al. Among authors: yee d. Breast Cancer Res Treat. 2000 Jul;62(2):109-15. doi: 10.1023/a:1006443720829. Breast Cancer Res Treat. 2000. PMID: 11016748
IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells.
Jackson JG, Yee D. Jackson JG, et al. Among authors: yee d. Growth Horm IGF Res. 1999 Oct;9(5):280-9. doi: 10.1054/ghir.1999.0113. Growth Horm IGF Res. 1999. PMID: 10543935
Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.
Rocha RL, Hilsenbeck SG, Jackson JG, VanDenBerg CL, Weng Cn, Lee AV, Yee D. Rocha RL, et al. Among authors: yee d. Clin Cancer Res. 1997 Jan;3(1):103-9. Clin Cancer Res. 1997. PMID: 9815544
Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
Gooch JL, Lee AV, Yee D. Gooch JL, et al. Among authors: yee d. Cancer Res. 1998 Sep 15;58(18):4199-205. Cancer Res. 1998. PMID: 9751635
IGF system components as prognostic markers in breast cancer.
Lee AV, Hilsenbeck SG, Yee D. Lee AV, et al. Among authors: yee d. Breast Cancer Res Treat. 1998 Feb;47(3):295-302. doi: 10.1023/a:1005915420341. Breast Cancer Res Treat. 1998. PMID: 9516083 Review.
Polyethylene glycol conjugated insulin-like growth factor binding protein-1 (IGFBP-1) inhibits growth of breast cancer in athymic mice.
Van den Berg CL, Cox GN, Stroh CA, Hilsenbeck SG, Weng CN, McDermott MJ, Pratt D, Osborne CK, Coronado-Heinsohn EB, Yee D. Van den Berg CL, et al. Among authors: yee d. Eur J Cancer. 1997 Jun;33(7):1108-13. doi: 10.1016/s0959-8049(97)00071-3. Eur J Cancer. 1997. PMID: 9376191
Interaction between insulin-like growth factor-I and insulin-like growth factor-binding proteins in TC-1 stromal cells.
Grellier P, Feliers D, Yee D, Woodruff K, Abboud SL. Grellier P, et al. Among authors: yee d. J Endocrinol. 1996 Jun;149(3):519-29. doi: 10.1677/joe.0.1490519. J Endocrinol. 1996. PMID: 8691111
654 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page